Serglycin in human cancers

Chinese Journal of Cancer

Volumn 30, Issue 9, 2011, Pages 585-589

  Li, Xin Jian ^a   Qian, Chao Nan ^a,b  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b VAN ANDEL RESEARCH INSTITUTE   (United States)

Author keywords

Cancer; Metastasis; Proteoglycan; Serglycin

Indexed keywords

CHEMOKINE; CYTOKINE; GLYCOSAMINOGLYCAN; MESSENGER RNA; PROTEINASE; PROTEOGLYCAN; SERGLYCIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AUTOCRINE EFFECT; CANCER CELL; CANCER GROWTH; CANCER INVASION; CARCINOGENESIS; CELL MOTILITY; CYTOKINE RELEASE; DISEASE FREE SURVIVAL; ENZYME RELEASE; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; HUMAN; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; NASOPHARYNX CARCINOMA; NONHUMAN; PARACRINE SIGNALING; PROGNOSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION;

ANTIGENS, CD44; AUTOCRINE COMMUNICATION; GLYCOSYLATION; HEMATOLOGIC NEOPLASMS; HUMANS; NASOPHARYNGEAL NEOPLASMS; NEOPLASM METASTASIS; PARACRINE COMMUNICATION; PROTEIN BINDING; PROTEOGLYCANS; RNA, MESSENGER; VESICULAR TRANSPORT PROTEINS;

EID: 80053090771     PISSN: 1000467X     EISSN: 1944446X     Source Type: Journal    
DOI: 10.5732/cjc.011.10314     Document Type: Review

References (54)

1. Schick BP. Regulatio n of expression of megakaryocyte and platelet proteoglycans [J]. Stem Cells, 1996,14 Suppl 1:220-231.
2. Bourdon MA, Oldberg A, Pierschbacher M, et al. Molecular cloning and sequence analysis of a chondroitin sulfate proteoglycan cDNA [J]. Proc Natl Acad Sci U S A, 1985,82(5): 1321-1325.
3. Okayama M, Oguri K, Fujiwara Y, et al. Purification and characterization of human platelet proteoglycan [J]. Biochem J, 1986,233(1):73-81.
4. Avraham S, Stevens RL, Nicodemus CF, et al. Molecular cloning of a cDNA that encodes the peptide core of a mouse mast cell secretory granule proteoglycan and comparison with the analogous rat and human cdna [J]. Proc Natl Acad Sci U S A, 1989,86(10):3763-3767.
5. Kolset SO, Tveit H. Serglycin-structure and biology [J]. Cell Mol Life Sci, 2008,65(7/8):1073-1085.
6. Nicodemus CF, Avraham S, Austen KF, et al. Characterization of the human gene that encodes the peptide core of secretory granule proteoglycans in promyelocytic leukemia HL-60 cells and analysis of the translated product [J]. J Biol Chem, 1990,265(10):5889-5896.
7. Kolset SO, Prydz K, Pejler G. Intracellular proteoglycans [J]. Biochem J, 2004,379(Pt 2):217-227.
8. Niemann CU, Cowland JB, Klausen P, et al. Localization of serglycin in human neutrophil granulocytes and their precursors [J]. J Leukoc Biol, 2004,76(2):406-415.
9. Niemann CU, Abrink M, Pejler G, et al. Neutrophil elastase depends on serglycin proteoglycan for localization in granules [J]. Blood, 2007,109(10):4478-4486.
10. Whitaker-Menezes D, Schechter NM, Murphy GF. Serine proteinases are regionally segregated within mast cell granules [J]. Lab Invest, 1995,72(1):34-41.
11. Grujic M, Braga T, Lukinius A, et al. Serglycin-deficient cytotoxic T lymphocytes display defective secretory granule maturation and granzyme B storage [J]. J Biol Chem, 2005,280(39):33411-33418.
12. Henningsson F, Hergeth S, Cortelius R, et al. A role for serglycin proteoglycan in granular retention and processing of mast cell secretory granule components [J]. Febs J, 2006,273 (21):4901-4912.
13. Braga T, Grujic M, Lukinius A, et al. Serglycin proteoglycan is required for secretory granule integrity in mucosal mast cells [J]. Biochem J, 2007,403(1):49-57.
14. Zernichow L, Dalen KT, Prydz K, et al. Secretion of proteases in serglycin transfected Madin-Darby canine kidney cells [J]. Febs J, 2006,273(3):536-547.
15. Humphries DE, Wong GW, Friend DS, et al. Heparin is essential for the storage of specific granule proteases in mast cells [J]. Nature, 1999,400(6746):769-772.
16. Toyama-Sorimachi N, Kitamura F, Habuchi H, et al. Widespread expression of chondroitin sulfate-type serglycins with CD44 binding ability in hematopoietic cells [J]. J Biol Chem, 1997,272(42):26714-26719.
17. Toyama-Sorimachi N, Miyasaka M. A sulfated proteoglycan as a novel ligand for CD44 [J]. J Dermatol, 1994,21(11):795-801.
18. Toyama-Sorimachi N, Sorimachi H, Tobita Y, et al. A novel ligand for CD44 is serglycin, a hematopoietic cell lineage-specific proteoglycan. Possible involvement in lymphoid cell adherence and activation [J]. J Biol Chem, 1995,270 (13): 7437-7444.
19. Schick BP, Gradowski JF, San Antonio JD. Synthesis, secretion, and subcellular localization of serglycin proteoglycan in human endothelial cells [J]. Blood, 2001,97(2):449-458.
20. Zernichow L, Abrink M, Hallgren J, et al. Serglycin is the major secreted proteoglycan in macrophages and has a role in the regulation of macrophage tumor necrosis factor-alpha secretion in response to lipopolysaccharide [J]. J Biol Chem, 2006,281 (37):26792-26801.
21. Winberg JO, Kolset SO, Berg E, et al. Macrophages secrete matrix metalloproteinase 9 covalently linked to the core protein of chondroitin sulphate proteoglycans [J]. J Mol Biol, 2000,304 (4):669-680.
22. Abrink M, Grujic M, Pejler G. Serglycin is essential for maturation of mast cell secretory granule [J]. J Biol Chem, 2004,279(39):40897-40905.
23. Niemann CU, Kjeldsen L, Ralfkiaer E, et al. Serglycin proteoglycan in hematologic malignancies: a marker of acute myeloid leukemia [J]. Leukemia, 2007,21(12):2406-2410.
24. Theocharis AD, Seidel C, Borset M, et al. Serglycin constitutively secreted by myeloma plasma cells is a potent inhibitor of bone mineralization in vitro [J]. J Biol Chem, 2006,281(46):35116-35128.
25. Skliris A, Happonen KE, Terpos E, et al. Serglycin inhibits the classical and lectin pathways of complement via its glycosaminoglycan chains: Implications for multiple myeloma [J]. Eur J Immunol, 2011,41(2):437-449.
26. Beyer-Sehlmeyer G, Hiddemann W, Wormann B, et al. Suppressive subtractive hybridisation reveals differential expression of serglycin, sorcin, bone marrow proteoglycan and prostate-tumour-inducing gene I (PTI-1) in drug-resistant and sensitive tumour cell lines of haematopoetic origin [J]. Eur J Cancer, 1999,35(12):1735-1742.
27. Li XJ, Ong CK, Cao Y, et al. Serglycin is a theranostic target in nasopharyngeal carcinoma that promotes metastasis [J]. Cancer Res, 2011,71(8):3162-3172.
28. Kolset SO, Zernichow L. Serglycin and secretion in human monocytes [J]. Glycoconj J, 2008,25(4):305-311.
29. Uhlin-Hansen L, Wik T, Kjellen L, et al. Proteoglycan metabolism in normal and inflammatory human macrophages [J]. Blood, 1993,82(9):2880-2889.
30. Ringvall M, Ronnberg E, Wernersson S, et al. Serotonin and histamine storage in mast cell secretory granules is dependent on serglycin proteoglycan [J]. J Allergy Clin Immunol, 2008,121 (4):1020-1026.
31. Kolset SO, Mann DM, Uhlin-Hansen L, et al. Serglycin-binding proteins in activated macrophages and platelets [J]. J Leukoc Biol, 1996,59(4):545-554.
32. Matsumoto R, Sali A, Ghildyal N, et al. Packaging of proteases and proteoglycans in the granules of mast cells and other hematopoietic cells. A cluster of histidines on mouse mast cell protease 7 regulates its binding to heparin serglycin proteoglycans [J]. J Biol Chem, 1995,270(33):19524-19531.
33. Serafin WE, Katz HR, Austen KF, et al. Complexes of heparin proteoglycans, chondroitin sulfate E proteoglycans, and [3H] diisopropyl fluorophosphates-binding proteins are exocytosed from activated mouse bone marrow-derived mast cells [J]. J Biol Chem, 1986,261(32):15017-15021.
34. Pejler G, Abrink M, Wernersson S. Serglycin proteoglycan: regulating the storage and activities of hematopoietic proteases [J]. Biofactors, 2009,35(1):61-68.
35. Lundequist A, Abrink M, Pejler G. Mast cell-dependent activation of pro matrix metalloprotease 2: a role for serglycin proteoglycan-dependent mast cell proteases [J]. J Biol Chem, 2006,387(10/11):1513-1519.
36. Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior [J]. Annu Rev Cell Dev Biol, 2001,17:463-516.
37. Metkar SS, Wang B, Aguilar-Santelises M, et al. Cytotoxic cell granule-mediated apoptosis: perforin delivers granzyme B-serglycin complexes into target cells without plasma membrane pore formation [J]. Immunity, 2002,16(3):417-428.
38. Galvin JP, Spaeny-Dekking LH, Wang B, et al. Apoptosis induced by granzyme B-glycosaminoglycan complexes: implications for granule-mediated apoptosis in vivo [J]. J Immunol, 1999,162(9):5345-5350.
39. Raja SM, Wang B, Dantuluri M, et al. Cytotoxic cell granule-mediated apoptosis. Characterization of the macromolecular complex of granzyme B with serglycin [J]. J Biol Chem, 2002,277(51):49523-49530.
40. Veugelers K, Motyka B, Goping IS, et al. Granule-mediated killing by granzyme B and perforin requires a mannose 6-phosphate receptor and is augmented by cell surface heparin sulfate [J]. Mol Biol Cell, 2006,17(2):623-633.
41. Melo FR, Waern I, Ronnberg E, et al. A role for serglycin proteoglycan in mast cell apoptosis induced by a secretory granule-mediated pathway [J]. J Biol Chem, 2011,286 (7): 5423-5433.
42. Kolset SO, Gallagher JT. Proteoglycans in haemopoietic cells [J]. Biochim Biophys Acta, 1990,1032(2/3):191-211.
43. Kolset SO, Vuong TT, Prydz K. Apical secretion of chondroitin sulphate in polarized madin-darby canine kidney (MDCK) cells [J]. J Cell Sci, 1999,112(Pt 11):1797-1801.
44. Mertens G, Van der Schueren B, van den Berghe H, et al. Heparan sulfate expression in polarized epithelial cells: the apical sorting of glypican (GPI-anchored proteoglycan) is inversely related to its heparan sulfate content [J]. J Cell Biol, 1996,132(3):487-497.
45. Hafte TT, Fagereng GL, Prydz K, et al. Protein core-dependent glycosaminoglycan modification and glycosaminoglycan-dependent polarized sorting in epithelial madin-darby canine kidney cells [J]. Glycobiology, 2011,21(4):457-466.
46. Meen AJ, Oynebraten I, Reine TM, et al. Serglycin is a major proteoglycan in polarized human endothelial cells and is implicated in the secretion of the chemokine GROalpha/CXCL1 [J]. J Biol Chem, 2011,286(4):2636-2647.
47. Biederbick A, Licht A, Kleene R. Serglycin proteoglycan is sorted into zymogen granules of rat pancreatic acinar cells [J]. Eur J Cell Biol, 2003,82(1):19-29.
48. Spring FA, Dalchau R, Daniels GL, et al. The Ina and Inb blood group antigens are located on a glycoprotein of 80,000 MW (the CDw44 glycoprotein) whose expression is influenced by the In(Lu) gene [J]. Immunology, 1988,64(1):37-43.
49. Zoller M. CD44: can a cancer-initiating cell profit from an abundantly expressed molecule? [J]. Nat Rev Cancer, 2011,11 (4):254-267.
50. Li C, Lee CJ, Simeone DM. Identification of human pancreatic cancer stem cells [J]. Methods Mol Biol, 2009,568:161-173.
51. Casagrande F, Cocco E, Bellone S, et al. Eradication of chemotherapy-resistant CD44 + human ovarian cancer stem cells in mice by intraperitoneal administration of clostridium perfringens enterotoxin [J]. Cancer, 2011 Jun 20. doi: 10.1002/cncr.26215. [Epub ahead of print]
52. Liu LL, Fu D, Ma Y, et al. The power and the promise of liver cancer stem cell markers [J]. Stem Cells Dev, 2011 Jun 8. [Epub ahead of print]
53. Ricardo S, Vieira AF, Gerhard R, et al. Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype [J]. J Clin Pathol, 2011 Jun 16. [Epub ahead of print]
54. Su YJ, Lai HM, Chang YW, et al. Direct reprogramming of stem cell properties in colon cancer cells by CD44 [J]. EMBO J, 2011,30(15):3186-3199.